Lexeo Therapeutics Inc (LXEO)

07:13 AM

What drives Lexeo Therapeutics Inc. stock priceFree Stock Market Return Analysis - Autocar Professional

07:13 AM

03:12 AM

Is Lexeo Therapeutics Inc. a good long term investmentBreakthrough profits - jammulinksnews.com

03:12 AM

01:49 AM

What analysts say about Lexeo Therapeutics Inc. stockFree Daily Trading Room Entry - Autocar Professional

01:49 AM

Jul 22, 2025

Lexeo Therapeutics Inc. Stock Analysis and ForecastHigh-return market picks - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Will Lexeo Therapeutics Inc. stock split in the near futureSafe and Smart Investment Picks - beatles.ru

Jul 19, 2025

Jul 18, 2025

Lexeo Therapeutics (NASDAQ:LXEO) & Organogenesis (NASDAQ:ORGO) Head to Head Analysis - Defense World

Jul 18, 2025

Jul 18, 2025

What analysts say about Lexeo Therapeutics Inc. stock outlookFree Investment Portfolio Suggestions - Newser

Jul 18, 2025

Jul 18, 2025

How high can Lexeo Therapeutics Inc. stock price go in 2025Safe and Smart Investment Picks - Newser

Jul 18, 2025

Jul 17, 2025

What makes Lexeo Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 17, 2025

Jul 15, 2025

Why Lexeo Therapeutics Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser

Jul 15, 2025

Jul 15, 2025

How Lexeo Therapeutics Inc. stock performs during market volatilityCarefully Curated High Return Stocks - Newser

Jul 15, 2025

Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal - Investing.com

Jul 11, 2025

Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target By Investing.com - Investing.com South Africa

Jul 07, 2025

Jul 07, 2025

Lexeo Therapeutics stock rises after FDA breakthrough designation By Investing.com - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

Lexeo Therapeutics Secures FDA Breakthrough Therapy Designation for LX2006, Shares Rise 8% in Pre-market Trade. - AInvest

Jul 07, 2025

Jul 07, 2025

Lexeo Therapeutics announces FDA Breakthrough Therapy Designation for LX2006 - TipRanks

Jul 07, 2025

Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia Treatment - Nasdaq

Jul 07, 2025

Jul 07, 2025

FDA grants breakthrough therapy designation to Lexeo’s FA treatment - Investing.com

Jul 07, 2025

Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia - GlobeNewswire

Jul 07, 2025

Jul 07, 2025

FDA Breakthrough: Lexeo's Gene Therapy Shows Promise in Fatal Rare Disease Treatment - Stock Titan

Jul 07, 2025

Jul 07, 2025

FDA grants breakthrough therapy designation to Lexeo’s FA treatment By Investing.com - Investing.com South Africa

Jul 07, 2025

Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan | ATNFW SEC FilingForm 8-K - Stock Titan

Jul 01, 2025

Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan - Stock Titan

Jul 01, 2025

Jun 30, 2025

Lexeo Therapeutics stockholders elect directors and ratify auditor at annual meeting - Investing.com

Jun 30, 2025

Jun 30, 2025

Lexeo Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 30, 2025

Jun 29, 2025

Lexeo Therapeutics, Inc.(NasdaqGM: LXEO) dropped from Russell 2000 Growth Index - MarketScreener

Jun 29, 2025

Jun 27, 2025

Lexeo Therapeutics, PXV Funds and venBio launch new entity to advance RNA therapies for cardiac diseases - Pharmafile

Jun 27, 2025

Jun 24, 2025

Lexeo to help launch spinout around RNA drugs for the heart - Yahoo Home

Jun 24, 2025

Jun 16, 2025

Bank of America Corp DE Trims Stock Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 16, 2025

Jun 14, 2025

Lexeo Therapeutics files to sell 41.63M shares of common stock for holders - MSN

Jun 14, 2025

Jun 14, 2025

Lexeo Therapeutics (LXEO) Proposes Sale of 41.63 Million Shares - GuruFocus

Jun 14, 2025

Jun 13, 2025

Lexeo Therapeutics Registers Share Offering on Behalf of Selling Stockholders - MarketScreener

Jun 13, 2025